Alphatec Holdings, Inc. ATEC

Latest FY: 2025 Healthcare Medical Devices
Market Price $9.79
Market Cap $1.50B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑25.0% YoY
$764.15M
3-Yr CAGR: 29.6%
Net Income ↑11.6% YoY
-$143.36M
Net Margin: -18.8%
Free Cash Flow ↑102.2% YoY
$2.78M
FCF Yield: 0.19%
EPS (Diluted) ↑15.0% YoY
$-0.96
Basic: $-0.96
Return on Equity Efficiency
-1,153.7%
ROA: -614.7%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ATEC)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $120.2M $76.1M $-29.9M $-3.49 $-10.0M $-18.9M
FY 2017 $101.7M -15.4% $62.3M $-2.3M +92.3% $-1.08 +69.1% $-8.7M $-16.3M +13.4%
FY 2018 $91.7M -9.9% $63.2M $-29.0M -1,163.1% $-1.20 -11.1% $-25.6M $-32.1M -96.8%
FY 2019 $113.4M +23.7% $77.6M $-57.0M -96.7% $-33.1M $-46.2M -43.7%
FY 2020 $144.9M +27.7% $102.5M $-79.0M -38.6% $-1.18 $-46.4M $-69.5M -50.7%
FY 2021 $243.2M +67.9% $157.8M $-144.3M -82.7% $-1.50 -27.1% $-73.4M $-142.0M -104.2%
FY 2022 $350.9M +44.3% $233.1M $-152.1M -5.4% $-1.47 +2.0% $-75.1M $-124.6M +12.2%
FY 2023 $482.3M +37.4% $310.2M $-186.6M -22.7% $-1.54 -4.8% $-78.5M $-159.0M -27.6%
FY 2024 $611.6M +26.8% $424.3M $-162.1M +13.1% $-1.13 +26.6% $-44.7M $-127.9M +19.6%
FY 2025 $764.2M +25.0% $531.9M $-143.4M +11.6% $-0.96 +15.0% $45.2M $2.8M +102.2%
$

Valuation

Market Price $9.79
Market Cap $1.50B
Enterprise Value $1.90B
P/E Ratio N/A
P/B Ratio 121.10
FCF Yield 0.19%
Dividend Yield N/A
Shares Outstanding 153,789,300
%

Profitability & Margins

Gross Margin 69.60%
Operating Margin -10.75%
Net Margin -18.76%
Return on Equity (ROE) -1,153.69%
Return on Assets (ROA) -614.69%
Asset Turnover 32.77x
Revenue 3-Yr CAGR 29.62%
🛡️

Financial Health & Liquidity

Current Ratio 0.24
Cash Ratio 1.66
Debt / Equity 45.545
Debt / Assets 24.266
Cash & Equivalents $160.81M
Total Debt $565.94M
Book Value / Share $0.08
💧

Cash Flow Efficiency

Operating Cash Flow $45.23M
Capital Expenditures (CapEx) $42.45M
Free Cash Flow $2.78M
OCF / Revenue 5.92%
FCF / Revenue 0.36%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.96
EPS (Basic) $-0.96
Dividends / Share N/A
Book Value / Share $0.08
EPS YoY Growth 15.04%
🏛️

Balance Sheet (FY 2025)

Total Assets $23.32M
Total Liabilities $97.02M
Stockholders' Equity $12.43M
Current Assets $23.32M
Current Liabilities $97.02M